STO:ASXSantos Limited Analysis
Data as of 2026-03-13 - not real-time
A$7.53
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Santos Limited (STO) is trading at AUD 7.53, comfortably above its 20‑day (7.09), 50‑day (6.73) and 200‑day (6.99) moving averages, while the RSI sits at 66 and the MACD shows a bullish crossover, indicating short‑term momentum support. Volume is trending upward and the market sentiment index reads 73.34 (Greed), suggesting investors are currently optimistic. However, the DCF‑derived fair value of only AUD 1.35 signals a stark valuation gap, and the company’s revenue has contracted -11.6% year‑over‑year, with a high debt‑to‑equity ratio of 48% and a payout ratio near 93%, raising questions about dividend sustainability. The stock’s 30‑day volatility of 34% and a beta of 0.49 reflect moderate price swings but lower market correlation, while the energy sector faces medium regulatory and geographic risks due to operations in Australia, Papua New Guinea and Timor‑Leste.
Given the blend of strong short‑term technicals, an attractive 4.63% dividend yield, and concerning fundamentals such as declining revenue and elevated leverage, the outlook is mixed: investors may consider a cautious buy for the near term, hold for the medium horizon, and monitor long‑term exposure to energy transition and debt servicing pressures.
Given the blend of strong short‑term technicals, an attractive 4.63% dividend yield, and concerning fundamentals such as declining revenue and elevated leverage, the outlook is mixed: investors may consider a cautious buy for the near term, hold for the medium horizon, and monitor long‑term exposure to energy transition and debt servicing pressures.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Price above all key moving averages
- Bullish MACD histogram
- Increasing trading volume
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Revenue decline of 11.6%
- High debt‑to‑equity ratio (48%)
- Attractive dividend yield but high payout ratio
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Energy transition and regulatory headwinds
- Strong cash flow but elevated leverage
- Sustained dividend income potential
Key Metrics & Analysis
Financial Health
Revenue Growth-11.60%
Profit Margin16.56%
P/E Ratio21.5
ROE5.24%
ROA2.35%
Debt/Equity48.13
P/B Ratio1.1
Op. Cash FlowA$2.8B
Free Cash FlowA$745.6M
Industry P/E22.2
Technical Analysis
TrendNeutral
RSI66.3
SupportA$6.42
ResistanceA$7.92
MA 20A$7.09
MA 50A$6.73
MA 200A$6.99
MACDBullish
VolumeIncreasing
Fear & Greed Index73.34
Valuation
Fair ValueA$1.35
Target PriceA$8.08
Upside/Downside7.28%
GradeOvervalued
TypeBlend
Dividend Yield4.63%
Risk Assessment
Beta0.49
Volatility34.28%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.